The number of member states of the European Union and the Schengen area accepting the Covishield vaccine as valid proof of immunity for incoming travelers has risen to 18, as Romania – an EU but not a Schengen country – also recognizes the vaccine.
According to the Romanian Ministry of Health, the state currently administers its own citizens and accepts the following vaccines as valid proof of immunity to enter its territory:
Comirnaty – Pfizer Moderna Vaxzervria – AstraZeneca Janssen – Johnson & Johnson Covishield (AstraZeneca – Serum Institute of India)
Travelers who have been vaccinated with any of these five vaccines can enter Romania without quarantine ten days after receiving the last shot of their vaccine. If travelers come from an area where the cumulative incidence of new COVID-19 cases in the last 14 days is less than or equal to 1.5 per 1,000 residents, the testing requirements will not apply to them.
The situation is different for travelers from countries classified as yellow, with the cumulative incidence of new COVID-19 cases in the last 14 days being between 1.5 and 3 per 1,000 population.
“Travelers arriving from countries classified as yellow, who do not submit a negative pre-departure PCR test performed within 72 hours prior to arrival, are subject to a 14-day quarantine. Children under the age of six are exempted from the PCR test requirements,” the Federation Commission notes. European Union in its guidelines for entry to Romania.
The first four vaccines listed above have been approved by the European Medicines Agency (EMA) and accepted by all countries of the European Union and the Schengen Area. The fourth is so far recognized by the following 18 countries.
Austria Belgium Bulgaria Croatia Croatia Finland France Germany Greece Hungary Iceland Ireland Latvia Netherlands Romania Slovenia Spain Sweden Switzerland
Covishield, the Astra Zeneca vaccine produced in India, is the most well-known vaccine for travel in the European Union after those approved by the EMA.
The same was listed by the World Health Organization for emergency use on February 15, along with the other version of AstraZeneca/Oxford, produced by AstraZeneca-SKBio in the Republic of Korea.
More than a month ago, in July, Somaya Swaminathan, an Indian clinical scientist who serves as the chief scientist for the World Health Organization (WHO), claimed that 15 countries in the European Union had accepted the AstraZeneca vaccine made in India as evidence of travel immunity. Since then, Croatia, Finland and Romania have joined the group.